Mechanisms of ALK Resistance & Implications for Treatment

Robert C. Doebele, M.D., Ph.D., GRACE Faculty

Dr. Robert Doebele of the University of Colorado Cancer Center spoke to ALK and ROS1 patients about how and why their cancers become resistant to treatment and what options are available.

 

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation